Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

• 1 April 2005
• journal article
• research article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 9  (15) , 1-157, iii
• https://doi.org/10.3310/hta9150

Abstract

Keywords

• ADULTS
• EPILEPSY
• NEWER
• PUBLISHED
• TOLERABILITY AND COST
• CLINICAL EFFECTIVENESS
• ASSESSMENT VOLUME
• HEALTH TECHNOLOGY
• EVALUATION HEALTH

Funding Information

• Health Technology Assessment Programme (01/50/01)